Year: 2022

Sonoco Announces Agreement to Acquire Westrock’s Remaining Interest in Joint Venture: RTS Packaging

Written by Customer Service on November 9, 2022. Posted in Mergers And Acquisitions.

Expands Sustainable Fiber-based Consumer Portfolio HARTSVILLE, S.C., Nov. 09, 2022 (GLOBE NEWSWIRE) — Sonoco Products Company (NYSE: SON) (“Sonoco” or the “Company”), a diversified global packaging leader, today announced it has entered a definitive agreement to purchase the remaining equity interest in RTS Packaging, LLC (“RTS”) from joint venture partner WestRock Company (“WestRock”) and one WestRock paper mill in Chattanooga, Tennessee, for $330 million in cash, subject to customary price adjustments. The valuation is approximately 6.6x adjusted EBITDA without synergies and 5x adjusted EBITDA pro forma for synergies. Sonoco also anticipates that it will be able to achieve $40 million of tax benefits from the transaction. Upon completion of the transaction, Sonoco will own 100% of RTS, formerly operated as a joint venture between...

Cool Company Ltd. – Q3 2022 Business Update

Written by Customer Service on November 9, 2022. Posted in Public Companies.

Cool Company Ltd. will host a Q3 2022 Business Update call and webcast presentation on Wednesday, November 16, 2022, at 10:30A.M. Oslo time. The presentation will be available to download from the Webcasts and Presentations subsection of the Investors section of the company website at www.coolcoltd.com We recommend that participants join the conference call via the listen-only live webcast link provided. Sell-side analysts interested in raising a question during the Q&A session that will immediately follow the presentation should access the event via the conference call by clicking on this link. We recommend connecting 10 minutes prior to call start. Information on how to ask questions will be given at the beginning of the Q&A session. There will be a limit of two questions per participant. a. Listen-only live webcast link Go...

Selectis Health to Present at the Rocky Mountain Microcap Conference X

Written by Customer Service on November 9, 2022. Posted in Public Companies.

Greenwood Village, CO, Nov. 09, 2022 (GLOBE NEWSWIRE) — Selectis Health, Inc. (OTC: GBCS) (“Selectis” or the “Company”), is scheduled to present at Trickle Research’s Rocky Mountain Microcap Conference X, which is being held at TopGolf in Centennial, Colorado on November 10, 2022. Selectis management is scheduled to present on Thursday, November 10th at 1:52 p.m. Mountain time. To receive additional information, request an invitation or schedule a one-on-one meeting with management, please contact Trickle Research or the Company’s investor relations team at selectis@gatewayir.com. About Selectis Health Selectis Health owns and/or operates healthcare facilities in Arkansas, Georgia, Ohio, and Oklahoma, providing a wide array of living services, speech, occupational, physical therapies, social services, and...

Grant of Incentive Subscription Rights in IDEX Biometrics 9 November 2022

Written by Customer Service on November 9, 2022. Posted in Public Companies.

The board of directors of IDEX Biometrics ASA resolved on 9 November 2022 to issue 2,470,000 incentive subscription rights to 15 new and continuing employees and individual contractors in the IDEX Biometrics group. The grant was made under the company’s 2022 incentive subscription rights plan as resolved at the annual general meeting on 12 May 2022. The exercise price of the subscription rights is NOK 1.03 per share. The subscription rights vest by 25% per year over four years and expire on 12 May 2027. Following the grants there are 83,111,447 incentive subscription rights outstanding in IDEX Biometrics. For further information contact:Marianne Bøe, Head of investor relations E-mail: marianne.boe@idexbiometrics.comTel: + 47 9180 0186 About IDEX BiometricsIDEX Biometrics ASA (OSE: IDEX and Nasdaq: IDBA) is a leading provider of fingerprint...

Optinose Announces ReOpen2 Presentation at the American College of Asthma, Allergy, and Immunology (ACAAI) 2022 Annual Scientific Meeting

Written by Customer Service on November 9, 2022. Posted in Public Companies.

YARDLEY, Pa., Nov. 09, 2022 (GLOBE NEWSWIRE) — Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that data from its ReOpen2 phase 3 clinical trial will be presented at the American College of Asthma, Allergy, and Immunology (ACAAI) 2022 Annual Scientific Meeting in Louisville, Kentucky on November 12, 2022. ReOpen2 was the second of two phase 3 clinical trials in its ReOpen Program which evaluated XHANCE, also referred to as the Exhalation Delivery System with fluticasone (EDS-FLU), as a potential treatment for chronic sinusitis. ePoster Presentation (P217): Randomized, Controlled Trial of Exhalation Delivery System with Fluticasone For Chronic Rhinosinusitis Without Nasal Polyps, is scheduled for Saturday, November 12, 2022 at 12:05...

EURO Ressources reports earnings for the third quarter and nine months ended September 30, 2022

Written by Customer Service on November 9, 2022. Posted in Earnings Releases And Operating Results.

NEWS RELEASE Paris: EUREURO RESSOURCES REPORTS EARNINGS FOR THE THIRD QUARTER AND NINE MONTHS ENDED SEPTEMBER 30, 2022 Paris, France, November 9, 2022: EURO Ressources S.A. (“EURO” or “the Company”) (Paris: EUR) today announced its unaudited statutory interim financial results prepared in accordance with International Financial Reporting Standards (“IFRS”) for the nine months ended September 30, 2022. These unaudited interim financial statements were approved by the Board of Directors on November 9, 2022. All financial amounts are expressed in Euros (“€” or “euros”) unless otherwise specified. Highlights Under IFRS, EURO reported a net profit of €2.9 million (€0.046 per share) and €9.3 million (€0.149 per share) for the three and nine months ended September 30, 2022, respectively, compared to €1.7 million (€0.026 per...

Exodus Reports Third Quarter 2022 Results

Written by Customer Service on November 9, 2022. Posted in Earnings Releases And Operating Results.

OMAHA, Neb., Nov. 09, 2022 (GLOBE NEWSWIRE) — Exodus Movement, Inc. (tZERO: EXOD), (“the Company” or “Exodus”) the leading self-custodial cryptocurrency software platform, today announced its fiscal 2022 results for the third quarter ended September 30, 2022. The Company reported third quarter revenue of $11.0 million, a decrease of 39% year-over-year. Third Quarter 2022 Financial HighlightsIn USD millions, except percentages Q3 2022 Q3 2021 % Change YTD 2022 YTD 2021 % ChangeTotal Revenue $11.0 $18.1 (39%) $39.4 $69.4 (43%)Total Cost of Revenues 6.6 6.9 (4%) 20.9 16.4 27%Operating Expenses 4.5 4.7 (4%) 24.2 16.3 48%(Loss) Income from Operations1 ($0.1 ) $6.5 (102%) ($5.7 ) $36.7 (116%)Operating Margin (1 %) 36 % (15 %) 53 % Net Income (Loss) ($1.3 ) $9.2 ($21.7 ) $31.3 Adjusted...

Nokia Corporation: Repurchase of own shares on 09.11.2022

Written by Customer Service on November 9, 2022. Posted in Public Companies.

Nokia CorporationStock Exchange Release9 November 2022 at 21:00 EET Nokia Corporation: Repurchase of own shares on 09.11.2022 Espoo, Finland – On 9 November 2022 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows:Trading venue (MIC Code) Number of shares Weighted average price / share, EUR*XHEL 352,904 4.47CEUX 75,278 4.47AQEU 29,653 4.48TQEX 32,665 4.47Total 490,500 4.47* Rounded to two decimals On 3 February 2022, Nokia announced that its Board of Directors is initiating a share buyback program under the authorization granted by Nokia’s Annual General Meeting on 8 April 2021 to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The first phase of the share buyback program in compliance with the Market Abuse Regulation...

AnaptysBio to Participate in Upcoming November Investor Conferences

Written by Customer Service on November 9, 2022. Posted in Public Companies.

SAN DIEGO, Nov. 09, 2022 (GLOBE NEWSWIRE) — AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced that Dan Faga, chief executive officer of AnaptysBio, will represent the company in a fireside chat at the Guggenheim 4th Annual Immunology and Neurology Conference on Monday November 14th, 2022, at 1:00 p.m. ET / 10:00 a.m. PT; members of its senior management team will also be hosting investor meetings at the Jefferies London Healthcare Conference on November 16th, 2022. A live audio webcast of the presentation will be available on the investor section of the AnaptysBio website at https://ir.anaptysbio.com/events. A replay of the webcast will be available for 30 days following the event. About AnaptysBio AnaptysBio is a clinical-stage biotechnology...

A New Step for Kenitra Site to Support Growth Plans for Middle East and Africa Region

Written by Customer Service on November 9, 2022. Posted in Public Companies.

A New Step for Kenitra Site to Support Growth Plans for Middle East and Africa RegionInvestment of over €300 million in Kenitra manufacturing facility in Morocco is part of region’s growth plans Kenitra plant to double local production capacity and introduce “smart car” platform to serve the commercial ambition of reaching more than 22% market share in the region by 2030 Kenitra plant to contribute to the regional ambition to have a production capacity of one million vehicles per year by 2030 with more than 70% production autonomyRABAT, MOROCCO, November 9, 2022 – At the occasion of meetings with the Moroccan Head of Government, the Minister of Industry and Trade, and the Minister Delegate to the Head of Government in charge of Investment, Convergence and Evaluation of Public Policies, Stellantis today announced an over €300 million...

Year: 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals